Celltrion, Inc.
068270
Ранг среди акций
#720
Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the... Celltrion, Inc., a South Korean biopharmaceutical company, specializes in the development and manufacturing of protein-based therapies, including treatments for oncology. Its commercial portfolio features established products such as Remsima, Truxima, and Herzuma, alongside a range of generic pharmaceuticals and diagnostic kits for COVID-19. The company maintains an extensive pipeline of antibody biosimilars currently undergoing various stages of clinical evaluation. Late-stage (Phase 3) candidates include CT-P17, aimed at rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease (IBD); CT-P16, targeting metastatic colorectal and breast cancers; CT-P43, for inflammatory conditions like psoriasis, Crohn's disease, and ulcerative colitis; CT-P42, addressing diabetic macular edema; and CT-P59, developed for COVID-19. In Phase 2, CT-P27 is being tested for pandemic and seasonal influenza. Earlier in development, Phase 1 assets comprise CT-P39 for asthma and urticaria, CT-P41 for osteoporosis and bone loss, and CT-G20 for cardiomyopathy. Additionally, Celltrion maintains a collaboration with Inhalon Biopharma, Inc. to advance IN-006, an inhaled formulation of regdanvimab intended for the treatment of COVID-19 patients. Established in 2002, the company operates primarily from its headquarters in Incheon, South Korea.
Цена акции
$146.63
Рыночная капитализация
$33.44B
Изменение (1 день)
-1.52%
Изменение (1 год)
23.60%
Страна
KR
Торговля Celltrion, Inc. (068270)
Категория
Healthcare
История дивидендов Celltrion, Inc. (068270)
Celltrion, Inc. (тикер: 068270) выплатила в общей сложности 10 дивидендов.
Общая сумма всех дивидендов (с учетом дроблений акций): $2.98K
Дивидендная доходность (TTM): 0.0037
Общая сумма всех дивидендов (с учетом дроблений акций): $2.98K
Дивидендная доходность (TTM): 0.0037
Дивидендные выплаты по Celltrion, Inc. (068270) с 2006 по 2026
Годовые дивидендные выплаты
| Год | Дивиденды (с учетом дробления акций) | Изменить |
|---|---|---|
| 2026 (TTM) | $714.29 | 0.00% |
| 2025 | $714.29 | 9.20% |
| 2024 | $654.11 | 50.00% |
| 2023 | $436.07 | 33.33% |
| 2022 | $327.05 | -48.00% |
| 2021 | $628.95 | 3,764.42% |
| 2012 | $16.28 | -77.75% |
| 2011 | $73.14 | 33.33% |
| 2010 | $54.85 | 50.00% |
| 2007 | $36.57 | 0.00% |
| 2006 | $36.57 | 0.00% |
Список всех дивидендных выплат
| Год | Дивиденд | Изменить |
|---|---|---|
| 2026 (TTM) | $750.00 | 0.00% |
| 2025 | $750.00 | 4.00% |
| 2024 | $721.15 | 50.00% |
| 2023 | $480.77 | 28.21% |
| 2022 | $375.00 | -49.02% |
| 2021 | $735.58 | 5,056.73% |
| 2012 | $14.26 | -85.17% |
| 2011 | $96.15 | 33.33% |
| 2010 | $72.12 | 50.00% |
| 2007 | $48.08 | 0.00% |
| 2006 | $48.08 | 0.00% |
Дивиденды аналогичных компаний или конкурентов
| Компания | Количество дивидендных выплат | Страна |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 67.00% |
AU
|
|
| 30.00% |
BE
|
|
| 0.00% |
NL
|
